A Phase II Study Evaluating the Safety and Efficacy of Sunitinib Malate in Combination With Weekly Paclitaxel Followed by Doxorubicin and Daily Oral Cyclophosphamide Plus G-CSF as Neoadjuvant Chemotherapy for Locally Advanced or Inflammatory Breast Cancer.
- DOI
- 10.1016/j.clbc.2021.05.009
- Published
- 2022 Jan
- Container
- Clinical breast cancer
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.clbc.2021.05.009,
title = {A Phase II Study Evaluating the Safety and Efficacy of Sunitinib Malate in Combination With Weekly Paclitaxel Followed by Doxorubicin and Daily Oral Cyclophosphamide Plus G-CSF as Neoadjuvant Chemotherapy for Locally Advanced or Inflammatory Breast Cancer.},
author = {Symonds L and Jenkins I and Linden HM and Kurland B and Gralow JR and Gadi VVK and Ellis GK and Wu Q and Rodler E and Chalasani P and Chai X and Riedel J and Scca Network Investigators and Stopeck A and Brown-Glaberman U and Specht JM},
year = {2022},
journal = {Clinical breast cancer},
doi = {10.1016/j.clbc.2021.05.009},
url = {https://doi.org/10.1016/j.clbc.2021.05.009}
}RIS
TY - JOUR TI - A Phase II Study Evaluating the Safety and Efficacy of Sunitinib Malate in Combination With Weekly Paclitaxel Followed by Doxorubicin and Daily Oral Cyclophosphamide Plus G-CSF as Neoadjuvant Chemotherapy for Locally Advanced or Inflammatory Breast Cancer. AU - Symonds L AU - Jenkins I AU - Linden HM AU - Kurland B AU - Gralow JR AU - Gadi VVK AU - Ellis GK AU - Wu Q AU - Rodler E AU - Chalasani P AU - Chai X AU - Riedel J AU - Scca Network Investigators AU - Stopeck A AU - Brown-Glaberman U AU - Specht JM PY - 2022 JO - Clinical breast cancer DO - 10.1016/j.clbc.2021.05.009 UR - https://doi.org/10.1016/j.clbc.2021.05.009 ER -
APA
L, S., I, J., HM, L., B, K., JR, G., VVK, G., GK, E., Q, W., E, R., P, C., X, C., J, R., Investigators, S. N., A, S., U, B., & JM, S. (2022). A Phase II Study Evaluating the Safety and Efficacy of Sunitinib Malate in Combination With Weekly Paclitaxel Followed by Doxorubicin and Daily Oral Cyclophosphamide Plus G-CSF as Neoadjuvant Chemotherapy for Locally Advanced or Inflammatory Breast Cancer.. Clinical breast cancer. https://doi.org/10.1016/j.clbc.2021.05.009
Source records
- pubmed · retrieved 2026-09-27T13:06:03.199Z